Comparative study of the in vitro antifungal activity of bifonazole, naftifine and sertaconazole against yeasts.
A J Carrillo-Muñoz, C Tur-Tur, F J Bornay-Llinares, P Arévalo
Index: J. Chemother. 11(3) , 187-90, (1999)
Full Text: HTML
Abstract
The in vitro activity of three antifungal agents was tested and compared against 151 yeast strains, including ten Candida species, Cryptococcus neoformans, Rhodotorula rubra, and Trichosporon cutaneum. Minimum inhibitory concentrations (MICs) were determined by a microdilution technique in Shadomy modified liquid medium. The mean MICs of sertaconazole (0.34 mg/L) were lower than those of naftifine (16.3 mg/L) and bifonazole (13.2 mg/L). These results suggest that sertaconazole is more active against Candida spp than other topical agents such as bifonazole and naftifine.
Related Compounds
Related Articles:
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.
2011-01-01
[Nucleic Acids Res. 39 , D1035-41., (2011)]
Allergic contact dermatitis from naftifine in a child without cross-reaction to terbinafine.
1998-07-01
[J. Eur. Acad. Dermatol. Venereol. 11(1) , 72-3, (1998)]
RIPK3-mediated necroptosis regulates cardiac allograft rejection.
2014-08-01
[Journal. of. Drugs in. Dermatology. 10(11) , 1282-8, (2011)]
2011-10-01
[Journal. of. Drugs in. Dermatology. 10(10) , 1142-7, (2011)]
Development of naftifine hydrochloride alcohol-free niosome gel.
2009-05-01
[Drug Dev. Ind. Pharm. 35(5) , 631-7, (2009)]